Stockreport

MindMed Reports First Quarter 2024 Financial Results and Business Updates

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF --Announced positive Phase 2b clinical trial results for MM120 in Generalized Anxiety Disorder (GAD), demonstrating clinically and statistically significant activity thr [Read more]